DILH
TARO

Dai-ichi Life Holdings’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Dai-ichi Life Holdings’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-20,134
Closed -$2.23M – 476
2016
Q3 		$2.23M Buy
+20,134
New +$2.67M 0.07% 291

Other funds holding TARO

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dai-ichi Life Holdings's TARO Position: Q4 2016 in Review

Dai-ichi Life Holdings sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2016, closing a stake of 20,134 shares — an estimated $2.23M sold.

Dai-ichi Life Holdings first reported a position in TARO in Q3 2016 and held it in 1 quarter. The position peaked at $2.23M in Q3 2016. 151 funds tracked by Wall St. Rank hold TARO as of Q4 2016.

  • Dai-ichi Life Holdings reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2016 after selling out during the quarter.
  • Dai-ichi Life Holdings sold 20,134 Taro Pharmaceutical Industries Ltd. shares in Q4 2016, an estimated $2.23M.
  • Dai-ichi Life Holdings first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2016 and held it in 1 quarter.
  • Dai-ichi Life Holdings's Taro Pharmaceutical Industries Ltd. position peaked at $2.23M in Q3 2016.
  • 151 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2016.

Based on Dai-ichi Life Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.